GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (CHIX:JNJd) » Definitions » Debt-to-Revenue

Johnson & Johnson (CHIX:JNJD) Debt-to-Revenue : 0.60 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Johnson & Johnson Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Johnson & Johnson's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was €12,855 Mil. Johnson & Johnson's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2025 was €35,478 Mil. Johnson & Johnson's annualized Revenue for the quarter that ended in Mar. 2025 was €81,004 Mil. Johnson & Johnson's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 was 0.60.


Johnson & Johnson Debt-to-Revenue Historical Data

The historical data trend for Johnson & Johnson's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson Debt-to-Revenue Chart

Johnson & Johnson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.43 0.43 0.50 0.34 0.41

Johnson & Johnson Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 0.46 0.40 0.41 0.60

Competitive Comparison of Johnson & Johnson's Debt-to-Revenue

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Debt-to-Revenue falls into.


;
;

Johnson & Johnson Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Johnson & Johnson's Debt-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(5713.765 + 29271.705) / 84824.055
=0.41

Johnson & Johnson's annualized Debt-to-Revenue for the quarter that ended in Mar. 2025 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(12854.725 + 35478.375) / 81004.1
=0.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2025) Revenue data.


Johnson & Johnson Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Address
One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson Headlines

No Headlines